Updated:
MX II Associates LLC
MX II Associates LLC is a venture capital firm headquartered in New York, United States, with a focus on biogenerics. The firm has a limited but targeted...
MX II Associates LLC
MX II Associates LLC is a venture capital firm headquartered in New York, United States, with a focus on biogenerics. The firm has a limited but targeted investment history, having made a single known investment in Coherus BioSciences as part of the company's Series A round on March 10, 2011. MX II Associates also achieved one portfolio exit through Coherus BioSciences on November 6, 2014. The firm's website is makassociates.net. Its investment approach centers on the biogenerics sector, reflecting a specialized interest within healthcare and life sciences.
General information
Firm type
Venture Capital
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, United States
Sector focus
Frequently asked questions
What is MX II Associates LLC's investment focus?
MX II Associates LLC focuses on the biogenerics sector within healthcare and life sciences.
What investment has MX II Associates LLC made?
The firm invested in Coherus BioSciences during its Series A round on March 10, 2011, and exited the position on November 6, 2014.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: